相关实验视频

Updated: Jan 15, 2026

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

杜恩肌肉发育不良症的基因疗法偏好:来自患者和护理人员采访的见解以及属性发展的见解

Thomas Desmet^1,2, Lauren Van Haesendonck¹, Sophie Vermeire¹

¹Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy KU Leuven, Leuven, Belgium.

Frontiers in pharmacology

|October 15, 2025

概括

这项研究确定了杜恩肌肉发育不良症 (DMD) 基因治疗的关键治疗特征,优先考虑肌肉和心脏功能,以及独立性. 这些发现将为未来的以患者为中心的治疗决策和DMD疗法的市场准入提供信息.

科学领域:

生物医学研究的研究.
患者报告的结果
基因治疗是一种基因疗法.

背景情况:

杜氏肌肉发育不良 (DMD) 是一种严重的X关联肌肉疾病,没有治愈.
目前的皮质类固醇治疗有显著的不良影响.
基因疗法为DMD治疗提供了一个有前途的新途径.

研究的目的:

确定关键的患者和护理人员对DMD治疗的偏好.
开发基因疗法定量偏好研究的属性.
为DMD基因疗法的市场准入和临床决策提供信息.

主要方法:

对DMD患者和护理人员进行了文献综述和半结构面试.
使用排名练习来确定关键的治疗特征.
应用的包含/排除标准和专家共识,用于属性开发.

主要成果:

从文献和采访中确定了48种独特的疾病和治疗特征.
在临床试验中发现高护理人员愿意考虑基因疗法.
关键的价值属性包括肌肉/心脏功能,自我照顾和独立.

结论:

确定了六个关键属性和水平,反映了患者对DMD基因治疗的优先事项.
定性研究和患者参与对于开发相关属性至关重要.
这些发现支持以患者为中心的未来定量偏好研究的发展.

关键词:

属性发展属性发展护理人员的观点,护理人员的观点.杜切恩肌肉发育不良症肌肉发育不良症基因治疗的基因疗法患者的偏好患者的偏好定性研究是指质量研究.半结构面试半结构面试半结构面试

更多相关视频

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

Pedigree Analysis

Pedigree Analysis